Home / Pharmaceutical company intelligence
Valor Pharmaceuticals logo
Pharmaceutical company intelligence

Valor Pharmaceuticals

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer producing a range of prescription and healthcare products for the Pakistan market.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
124/A, Kahuta Triangle Zone Industrial Area, Islamabad, Pakistan
Phone
+92 51 4491616
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000496 Valor Pharmaceuticals. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000496 218 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx229public portfolio records represented
REG196unique registrations represented
IDX18indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER9registry-verified exact registrations
PKR219current validated price records
G97generic molecules in indexed catalogue
DF12dosage-form groups
TA15therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage96%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage79%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixValor PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/valor-pharmaceuticalsGenerated 24 Sep 2026Anti-infectives104 · 47%Dermatology24 · 11%CNS & mental health20 · 9%Cardiovascular14 · 6%Vitamins, minerals & nutrition12 · 5%Pain & musculoskeletal12 · 5%Endocrine & metabolic6 · 3%Other therapeutic areas27 · 12%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioValor PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/valor-pharmaceuticalsGenerated 24 Sep 2026219presentationsTablet89 · 41%Capsule39 · 18%Cream28 · 13%Suspension14 · 6%Ointment13 · 6%Drops9 · 4%Other forms27 · 12%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionValor PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/valor-pharmaceuticalsGenerated 24 Sep 2026174comparable productsBelow peer median53 · 30%Near peer median71 · 41%Above peer median50 · 29%Company median price position+0.0%Lowest-price equivalents19Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsValor PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/valor-pharmaceuticalsGenerated 24 Sep 2026Atco Laboratories Limited44 shared45% overlapNeutro Pharma (Pvt.) Ltd.,44 shared45% overlapNabiqasim Industries (Pvt) Ltd.,43 shared44% overlapMediate Pharmaceutical Pvt Ltd39 shared40% overlapCCL Pharmaceuticals (Pvt.) Limited36 shared37% overlapBio-Labs(Pvt) Ltd36 shared37% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives104 products · 47%
Dermatology24 products · 11%
CNS & mental health20 products · 9%
Cardiovascular14 products · 6%
Vitamins, minerals & nutrition12 products · 5%
Pain & musculoskeletal12 products · 5%
Endocrine & metabolic6 products · 3%
Hematology & thrombosis6 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antifungals18 products · 8%
Fluoroquinolone antibacterials17 products · 8%
Topical corticosteroids / anti-inflammatory dermatologics14 products · 6%
Vitamins / minerals / hematinics12 products · 5%
Antivirals12 products · 5%
Analgesics / NSAIDs12 products · 5%
Macrolide antibacterials11 products · 5%
Retinoids / anti-acne medicines10 products · 5%
Formulation footprint

Dosage forms

Tablet89 products
Capsule39 products
Cream28 products
Suspension14 products
Ointment13 products
Drops9 products
Lotion8 products
Gel7 products
Sachet4 products
Solution4 products
Injection3 products
Pessary1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CaricinClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #2 RibavalRibavirin 5presentations 100 mg, 200 mg, 400 mg · Capsule #3 SeptinilPovidone-iodine 5presentations 10 %, 10%, 7.5% · Gel, Solution #4 BetavalBetamethasone valerate 4presentations 0.1 %, 0.1% · Ointment, Cream #5 CortivalHydrocortisone 4presentations 1 %, 1%, 2.5%, 2% · Cream #6 CylorCiclosporin 4presentations 0.5 mg, 100 mg, 25 mg, 50 mg · Drops, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5330% of comparable products
Near market median71within ±5% of median
Above market median5029% of comparable products
Lowest-price equivalents19ties included
Company median price position +0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Prufo 600 mgIbuprofen · Tablet · 60x10’s PKR 1.66/tablet-74.1% vs market median Ribaval 400 mgRibavirin · Capsule · 3x10's PKR 16.49/capsule-71.4% vs market median Ribaval 400 mgRibavirin · Capsule · 2x10's PKR 17.05/capsule-70.4% vs market median Ribaval 400 mgRibavirin · Capsule · 10's PKR 17.95/capsule-68.9% vs market median Mucocyst 200 mgAcetylcysteine · Sachet · 30's PKR 5.53/sachet-65.1% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Atco Laboratories Limited278 products · 94 generics 44shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 44shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 43shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 39shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 36shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 36shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers186Distinct registrations among indexed, published, presentation-validated products only
Verified price observations421
Products with a verified price219
Products with multiple price observations202
Source records with multiple versions217
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

196 unique registration(s) · 18 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Drug classAntifungals Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Cremazole Clotrimazole 1 % Vaginal cream 10gm 046071 PKR 63.82 PKR 6.38/g No comparator
Cremazole Clotrimazole 1% Lotion 30ml 049051 PKR 59.85 PKR 2.00/mL 7% below median
Cremazole Clotrimazole + Hydrocortisone 10 mg + 10 mg Cream 10gm 054819 PKR 123.59 PKR 12.36/g 8% above median
Cremazole - S Clotrimazole 1 % Cream 10gm 066354 PKR 63.82 PKR 6.38/g Near median
Cremazole H Clotrimazole + Hydrocortisone 10 mg/g + 10 mg/g Cream 10gm 054819 PKR 123.59 PKR 12.36/g 14% above median
Flucoval Fluconazole 150 mg Capsule 1's 065434 PKR 275.27 PKR 275.27/capsule Near median
Flucoval Fluconazole 50 mg/5 mL Suspension 35ml 073174 PKR 418.88 PKR 11.97/mL Near median
Itraval Itraconazole 100 mg Capsule 4's 065105 PKR 598.41 PKR 149.60/capsule Near median
Mycon Miconazole 2 % Cream 10gm 027866 PKR 83.78 PKR 8.38/g 23% above median
Mycon Miconazole 2% Cream 40gm 027866 PKR 309.18 PKR 7.73/g No comparator
Mycon Miconazole 2 % Gel 20 gm 070057 PKR 169.55 PKR 8.48/g Near median
Mycon-H Miconazole + Hydrocortisone 2% + 1% Cream 10gm 027865 PKR 121.67 PKR 12.17/g 28% above median
T-Fin Terbinafine 1 % Cream 10gm 075317 PKR 294.42 PKR 29.44/g Near median
Vagizole Clotrimazole 2% Cream 35gm 034763 PKR 180.67 PKR 5.16/g 43% above median
Vagizole Clotrimazole 500 mg Vaginal tablet 1’s 041006 PKR 127.66 PKR 127.66/tablet Near median
Vagizole Clotrimazole 10% Cream 5gm 072893 PKR 139.72 PKR 27.94/g Near median
Vagizole Vaginal Clotrimazole 100 mg Tablet 1x6’s 034826 PKR 119.68 PKR 19.95/tablet 8% below median
Valozole Voriconazole 200 mg Tablet 10's 101562 PKR 2,180.34 PKR 218.03/tablet 7% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Valor Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/valor-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.